MedPath

Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation

Phase 3
Completed
Conditions
Irritable Bowel Syndrome Characterized by Constipation
Interventions
Drug: Matching placebo
Registration Number
NCT00948818
Lead Sponsor
Forest Laboratories
Brief Summary

The objective of this trial is to determine the efficacy and safety of linaclotide administered to patients with irritable bowel syndrome with constipation (IBS-C).

The primary efficacy parameter is the percentage of patients in each treatment group that meet the protocol definition for Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
803
Inclusion Criteria
  • Patient meets protocol criteria for IBS: reports abdominal discomfort or pain that has two or more of the following three features:

    1. Relieved with defecation
    2. Onset associated with a change in frequency of stool
    3. Onset associated with a change in form (appearance) of stool
  • Patient reports < 3 bowel movements (BMs) per week (in the absence of any laxative, suppository, or enema use during the preceding 24 hours) and reports straining, lumpy or hard stools, and/or sensation of incomplete evacuation during > 25% of BMs

  • Patient has successfully completed protocol procedures (with no clinically significant findings): physical exam, 12-lead ECG, or clinical laboratory tests (some patients may require a colonoscopy per American Gastroenterological Association (AGA) guidelines)

  • Patient is compliant with Interactive Voice Response System (IVRS) for daily diary reporting of BM habits and IBS symptoms

Exclusion Criteria
  • Patient has history of loose or watery stools for >25% of BMs
  • Patient has a structural abnormality of the gastrointestinal (GI) tract or a history of a disease or condition that can affect GI motility
  • Patient has any protocol-excluded or clinically significant medical or surgical history or concomitant medication use that could confound the study assessments

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LinaclotideLinaclotide 290 microgramsLinaclotide 290 micrograms
PlaceboMatching placeboMatching placebo
Primary Outcome Measures
NameTimeMethod
Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 9 Out of 12 WeeksChange from Baseline to Week 12

A patient is considered to be an APC responder if, for at least 9 out of the 12 weeks of the treatment period, the patient had at least 3 CSBMs, experienced an increase of at least 1 CSBM from baseline, and experienced a decrease of at least 30 percent in their Abdominal Pain (AP) score from baseline during a particular week.

The AP score assesses the worst of a patient's AP in the past 24 hours using an 11-point scale (from 0-10), where 0 represents no AP and 10 represents very severe AP.

A CSBM is defined as a spontaneous bowel movement, associated with a sense of complete evacuation.

Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder, 9 Out of 12 WeeksChange from Baseline to Week 12

A patient is considered to be a CSBM 3+1 responder if, for at least 9 out of the 12 weeks of the treatment period, the patient had at least 3 CSBMs and experienced an increase of at least 1 CSBM from baseline during a particular week.

A CSBM was defined as a Spontaneous Bowel Movement (SBM) that was associated with a sense of complete evacuation.

An SBM was defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM.

Abdominal Pain Responder, 9 Out of 12 WeeksChange from Baseline to Week 12

A patient is considered to be an abdominal pain responder if, for at least 9 out of the 12 weeks of the treatment period, they experienced a decrease of at least 30 percent in the mean abdominal pain score from baseline during a particular week.

The Abdominal Pain score assesses the worst of a patient's abdominal pain in the past 24 hours using an 11-point scale (from 0-10), where 0 represents no abdominal pain and 10 represents very severe abdominal pain.

Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 6 Out of 12 Weeks.Change from Baseline to Week 12

A patient is considered an APC responder if, for at least 6 of the 12 weeks of the treatment, the patient experienced an increase of at least 1 Complete Spontaneous Bowel Movement (CSBM) from baseline and experienced a decrease of at least 30 percent in their Abdominal Pain (AP)score during a particular week.

The AP score assesses the worst of a patient's AP in the past 24 hours using an 11-point scale (from 0-10), where 0 represents no AP and 10 represents very severe AP.

A CSBM was defined as a Spontaneous Bowel Movement (SBM) that was associated with a sense of complete evacuation.

Secondary Outcome Measures
NameTimeMethod
12-Week Complete Spontaneous Bowel Movement (CSBM) Frequency RateChange from Baseline to Week 12

The number of CSBMs per week.

12-Week Spontaneous Bowl Movement (SBM) Frequency RateChange from Baseline to Week 12

The number of Spontaneous Bowl Movements experienced per week.

12-Week Stool ConsistencyChange from Baseline to Week 12

The consistency of each BM was assessed by patients using the 7-point Bristol Stool Form Scale (BSFS) from 1 to 7.

1. = separate hard lumps like nuts \[difficult to pass\]

2. = sausage shaped but lumpy

3. = like a sausage but with cracks on surface

4. = like a sausage or snake, smooth and soft

5. = soft blobs with clear-cut edges \[passed easily\]

6. = fluffy pieces with ragged edges, a mushy stool

7. = watery, no solid pieces \[entirely liquid\]).

12-Week Severity of StrainingChange from Baseline to Week 12

Straining is measured on a 5-point scale where a value of 1 is "not at all" and a value of 5 is "an extreme amount.

12-Week Change in Abdominal Pain ScoreChange from Baseline to Week 12

Abdominal Pain at its worst (in the last 24 hours) is based on an 11-point scale where 0 represents no abdominal pain and 10 represents very severe abdominal pain.

12-Week Change in Abdominal DiscomfortChange from Baseline to Week 12

Abdominal Discomfort is measured on an 11-point scale where a value of 0 is "none" and a value of 10 is "very severe."

12-Week Change in BloatingChange from Baseline to Week 12

Bloating was assessed on an 11-point scale where a value of 0 is "none" and a value of 10 is "very severe".

Complete Spontaneous Bowl Movement (CSBM) Responder for 6 Weeks Out of 12 Weeks of TreatmentChange from Baseline to Week 12

A patient is considered to be a CSBM responder if, for at least 6 out of the 12 weeks of the treatment period, an increase of at least 1 CSBM per week from baseline was experienced.

Abdominal Pain Responder for 6 Out of 12 WeeksChange from Baseline to Week 12

A patient is considered to be an abdominal pain responder if, for at least 6 out of the 12 weeks of the treatment period, they experienced a decrease of 30 percent or more in the abdominal pain score from baseline.

The Abdominal Pain score assesses the worst of a patient's abdominal pain in the past 24 hours using an 11-point scale (from 0-10), where 0 represents no abdominal pain and 10 represents very severe abdominal pain.

12-Week Percent of Abdominal Pain-free (APF) DaysChange from Baseline to Week 12

Abdominal pain free (APF) days are those days where the patient reported a score of '0' for abdominal pain at its worst

Abdominal Pain at its worst (in the last 24 hours) is based on an 11-point scale where 0 represents no abdominal pain and 10 represents very severe abdominal pain.

Trial Locations

Locations (118)

Forest Investigative Site 057

🇺🇸

Los Angeles, California, United States

Forest Investigative Site 032

🇺🇸

Atlanta, Georgia, United States

Forest Investigative Site 001

🇺🇸

Boston, Massachusetts, United States

Forest Investigative Site 044

🇺🇸

Cleveland, Ohio, United States

Forest Investigative Site 113

🇨🇦

Sudbury, Ontario, Canada

Forest Investigative Site 094

🇺🇸

Burbank, California, United States

Forest Investigative Site 026

🇺🇸

Encinitas, California, United States

Forest Investigative Site 005

🇺🇸

Orange, California, United States

Forest Investigative Site 053

🇺🇸

Mesa, Arizona, United States

Forest Investigative Site 097

🇺🇸

Mission Hills, California, United States

Forest Investigative Site 074

🇺🇸

Longmont, Colorado, United States

Forest Investigative Site 018

🇺🇸

Ft. Myers, Florida, United States

Forest Investigative Site 096

🇺🇸

Foothill Ranch, California, United States

Forest Investigative Site 080

🇺🇸

Chandler, Arizona, United States

Forest Investigative Site 078

🇺🇸

Peoria, Arizona, United States

Forest Investigative Site 108

🇺🇸

Ocala, Florida, United States

Forest Investigative Site 014

🇺🇸

Huntsville, Alabama, United States

Forest Investigative Site 051

🇺🇸

Scottsdale, Arizona, United States

Forest Investigative Site 042

🇺🇸

Boca Raton, Florida, United States

Forest Investigative Site 058

🇺🇸

Waterbury, Connecticut, United States

Forest Investigative Site 070

🇺🇸

Brooksville, Florida, United States

Forest Investigative Site 068

🇺🇸

Zephyrhills, Florida, United States

Forest Investigative Site 029

🇺🇸

Arkansas City, Kansas, United States

Forest Investigative Site 125

🇺🇸

Kalamazoo, Michigan, United States

Forest Investigative Site 006

🇺🇸

Hagerstown, Maryland, United States

Forest Investigative Site 104

🇺🇸

Trinity, Florida, United States

Forest Investigative Site 033

🇺🇸

Marietta, Georgia, United States

Forest Investigative Site 046

🇺🇸

Iowa City, Iowa, United States

Forest Investigative Site 073

🇺🇸

Lutherville, Maryland, United States

Forest Investigative Site 047

🇺🇸

Evansville, Indiana, United States

Forest Investigative Site 134

🇺🇸

Setauket, New York, United States

Forest Investigative Site 124

🇺🇸

Shreveport, Louisiana, United States

Forest Investigative Site 009

🇺🇸

Newton, Kansas, United States

Forest Investigative Site 093

🇺🇸

Wichita, Kansas, United States

Forest Investigative Site 023

🇺🇸

Wichita, Kansas, United States

Forest Investigative Site 037

🇺🇸

Birmingham, Alabama, United States

Forest Investigative Site 036

🇺🇸

Birmingham, Alabama, United States

Forest Investigative Site 128

🇺🇸

Phoenix, Arizona, United States

Forest Investigative Site 101

🇺🇸

Phoenix, Arizona, United States

Forest Investigative Site 034

🇺🇸

Denver, Colorado, United States

Forest Investigative Site 133

🇺🇸

Miami, Florida, United States

Forest Investigative Site 031

🇺🇸

Miami, Florida, United States

Forest Investigative Site 028

🇺🇸

Cincinnati, Ohio, United States

Forest Investigative Site 082

🇺🇸

Oklahoma City, Oklahoma, United States

Forest Investigative Site 025

🇺🇸

Nashville, Tennessee, United States

Forest Investigative Site 041

🇺🇸

Houston, Texas, United States

Forest Investigative Site 110

🇺🇸

Houston, Texas, United States

Forest Investigative Site 095

🇺🇸

San Antonio, Texas, United States

Forest Investigative Site 076

🇺🇸

San Antonio, Texas, United States

Forest Investigative Site 089

🇺🇸

Salt Lake City, Utah, United States

Forest Investigative Site 091

🇺🇸

Salt Lake City, Utah, United States

Forest Investigative Site 100

🇺🇸

Salt Lake City, Utah, United States

Forest Investigative Site 115

🇨🇦

Sarnia, Ontario, Canada

Forest Investigative Site 135

🇺🇸

Hueytown, Alabama, United States

Forest Investigative Site 077

🇺🇸

Kissimmee, Florida, United States

Forest Investigative Site 136

🇺🇸

Tucson, Arizona, United States

Forest Investigative Site 024

🇺🇸

Westlake Village, California, United States

Forest Investigative Site 087

🇺🇸

Tucson, Arizona, United States

Forest Investigative Site 021

🇺🇸

Boulder, Colorado, United States

Forest Investigative Site 019

🇺🇸

Colorado Springs, Colorado, United States

Forest Investigative Site 010

🇺🇸

Wheat Ridge, Colorado, United States

Forest Investigative Site 030

🇺🇸

Jupiter, Florida, United States

Forest Investigative Site 003

🇺🇸

Bradenton, Florida, United States

Forest Investigative Site 129

🇺🇸

New Smyrna Beach, Florida, United States

Forest Investigative Site 027

🇺🇸

Pembroke Pines, Florida, United States

Forest Investigative Site 040

🇺🇸

Woodstock, Georgia, United States

Forest Investigative Site 103

🇺🇸

Atlanta, Georgia, United States

Forest Investigative Site 015

🇺🇸

Tampa, Florida, United States

Forest Investigative Site 085

🇺🇸

Vineland, New Jersey, United States

Forest Investigative Site 043

🇺🇸

Rockford, Illinois, United States

Forest Investigative Site 064

🇺🇸

Chaska, Minnesota, United States

Forest Investigative Site 137

🇺🇸

Brandon, Florida, United States

Forest Investigative Site 045

🇺🇸

St. Petersburg, Florida, United States

Forest Investigative Site 038

🇺🇸

Panama City, Florida, United States

Forest Investigative Site 020

🇺🇸

Marietta, Georgia, United States

Forest Investigative Site 055

🇺🇸

Idaho Falls, Idaho, United States

Forest Investigative Site 013

🇺🇸

Chevy Chase, Maryland, United States

Forest Investigative Site 132

🇺🇸

Baton Rouge, Louisiana, United States

Forest Investigative Site 067

🇺🇸

Lexington, Kentucky, United States

Forest Investigative Site 004

🇺🇸

St. Louis, Missouri, United States

Forest Investigative Site 011

🇺🇸

Great Neck, New York, United States

Forest Investigative Site 035

🇺🇸

Brooklyn, New York, United States

Forest Investigative Site 052

🇺🇸

Albuquerque, New Mexico, United States

Forest Investigative Site 017

🇺🇸

Great Neck, New York, United States

Forest Investigative Site 122

🇺🇸

Boone, North Carolina, United States

Forest Investigative Site 016

🇺🇸

Greensboro, North Carolina, United States

Forest Investigative Site 088

🇺🇸

Raleigh, North Carolina, United States

Forest Investigative Site 072

🇺🇸

Fayetteville, North Carolina, United States

Forest Investigative Site 119

🇺🇸

Hickory, North Carolina, United States

Forest Investigative Site 056

🇺🇸

Wilmington, North Carolina, United States

Forest Investigative Site 065

🇺🇸

Winston-Salem, North Carolina, United States

Forest Investigative Site 123

🇺🇸

Columbus, Ohio, United States

Forest Investigative Site 130

🇺🇸

Dayton, Ohio, United States

Forest Investigative Site 039

🇺🇸

Pittsburgh, Pennsylvania, United States

Forest Investigative Site 102

🇺🇸

Tulsa, Oklahoma, United States

Forest Investigative Site 131

🇺🇸

Greer, South Carolina, United States

Forest Investigative Site 121

🇺🇸

Greenville, South Carolina, United States

Forest Investigative Site 069

🇺🇸

Greer, South Carolina, United States

Forest Investigative Site 002

🇺🇸

Dallas, Texas, United States

Forest Investigative Site 099

🇺🇸

Austin, Texas, United States

Forest Investigative Site 063

🇺🇸

Lake Jackson, Texas, United States

Forest Investigative Site 054

🇺🇸

Charlottesville, Virginia, United States

Forest Investigative Site 060

🇺🇸

Norfolk, Virginia, United States

Forest Investigative Site 050

🇺🇸

Richmond, Virginia, United States

Forest Investigative Site 007

🇺🇸

Newport News, Virginia, United States

Forest Investigative Site 075

🇺🇸

Norfolk, Virginia, United States

Forest Investigative Site 061

🇺🇸

Christianburg, Virginia, United States

Forest Investigative Site 049

🇺🇸

Bellevue, Washington, United States

Forest Investigative Site 098

🇺🇸

Lakewood, Washington, United States

Forest Investigative Site 112

🇨🇦

New Market, Ontario, Canada

Forest Investigative Site 107

🇨🇦

Hamilton, Ontario, Canada

Forest Investigative Site 066

🇺🇸

Wenatchee, Washington, United States

Forest Investigative Site 083

🇺🇸

Milwaukee, Wisconsin, United States

Forest Investigative Site 106

🇨🇦

Ottawa, Ontario, Canada

Forest Investigative Site 116

🇨🇦

Toronto, Ontario, Canada

Forest Investigative Site 008

🇨🇦

Toronto, Ontario, Canada

Forest Investigative Site 092

🇺🇸

Orlando, Florida, United States

Forest Investigative Site 114

🇺🇸

Madisonville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath